KTRA : Insider Transactions for Kintara Therapeutics, Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Kintara Therapeutics, Inc (KTRA)

$0.08 0.00 (0.00%) as of 4:30 Fri 11/11

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

1,680,000

Market Cap:

141.29(K)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.0841 - $0.0841

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Kintara Therapeutics is a clinical stage, biopharmaceutical company focused on the development and commercialization of new cancer therapies. Co.'s two primary candidates are: VAL-083, a validated, DNA-targeting agent, for the treatment of drug-resistant solid tumors such as glioblastoma multiforme and potentially other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a late-stage photodynamic therapy for the treatment of cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and access graft failure in hemodialysis patients.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	0	0	0	0
Total Sell Value	$0	$0	$0	$0
Total People Sold	0	0	0	0
Total Sell Transactions	0	0	0	0
End Date	2024-03-03	2023-12-01	2023-06-02	2022-06-02

Adjust Filter Settings

Records found: 165

Page 5 of 7

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Toth Robert Joseph Jr

Director

– • –

2017-06-30

4

A

$3.20

$237

D/D

74

11,221

-

Chief Financial Officer

• – –

2017-06-30

4

A

$3.20

$675

D/D

211

29,655

-

Director

– • –

2017-06-30

4

A

$3.20

$1,690

D/D

528

6,638

-

Chief Scientific Officer

• • –

2017-06-30

4

A

$3.20

$541

I/I

169

885,177

-

Cranston Lynda Sarah

Director

– • –

2017-06-30

4

A

$3.20

$227

I/I

71

2,415

-

CEO

• • –

2017-06-30

4

A

$3.20

$563

D/D

176

53,521

-

Director

– • –

2017-06-30

4

A

$3.20

$902

I/I

282

49,737

-

Chief Financial Officer

• – –

2017-06-26

4

B

$3.60

$15,001

D/D

4,167

29,444

2.74

-

Director

– • –

2017-06-26

4

B

$3.60

$15,001

I/I

4,167

49,455

2.1

-

Director

– • –

2017-06-26

4

B

$3.60

$15,001

D/D

4,167

6,110

2.39

-

Cranston Lynda Sarah

Director

– • –

2017-06-26

4

B

$3.60

$7,499

I/I

2,083

2,344

2.1

-

CEO

• • –

2017-06-26

4

B

$3.60

$24,120

D/D

6,700

53,345

2.81

-

Director

– • –

2017-06-06

4

B

$2.12

$21,200

I/I

10,000

45,288

2.1

-

Chief Financial Officer

• – –

2017-06-06

4

B

$2.10

$19,950

D/D

9,500

25,277

2.74

-

CEO

• • –

2017-06-06

4

B

$2.12

$10,600

D/D

5,000

46,645

2.81

-

Chief Executive Officer

• • –

2017-05-05

4

B

$2.20

$5,500

D/D

2,500

41,645

2.81

-

Chief Executive Officer

• • –

2017-03-31

4

A

$3.20

$563

D/D

176

39,145

-

Toth Robert Joseph Jr

Director

– • –

2017-03-31

4

A

$3.20

$237

D/D

74

11,147

-

Cranston Lynda Sarah

Director

– • –

2017-03-31

4

A

$3.20

$227

I/I

71

261

-

Director

– • –

2017-03-31

4

A

$3.20

$1,690

D/D

528

1,943

-

Chief Financial Officer

• – –

2017-03-31

4

A

$3.20

$675

D/D

211

15,777

-

Director

– • –

2017-03-31

4

A

$3.20

$902

I/I

282

35,288

-

Chief Scientific Officer

• • –

2017-03-31

4

A

$3.20

$541

I/I

169

885,008

-

CEO

• • –

2017-02-01

4

B

$5.00

$20,000

D/D

4,000

38,969

2.81

-

Chief Financial Officer

• – –

2016-12-31

4

A

$3.20

$675

D/D

211

15,566

-

165 Records found	1 2 3 4 5 6 7	Page 5 of 7

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.